Publications by authors named "Yusaku Saijo"

Background: Keloids are growing scars that arise from injury to the reticular dermis and subsequent chronic local inflammation. The latter may be promoted by vascular hyperpermeability, which permits the ingress of chronic inflammatory cells/factors. Cutaneous capillaries consist of endothelial cells that generate, and are anchored by, a vascular basement membrane (VBM).

View Article and Find Full Text PDF

Tie-over bolster fixation is the most common method of securing a skin graft. The bolster material can consist of various materials, including sterilized polyurethane foam. Mepilex Ag is a silver-containing polyurethane-foam wound-dressing material that has a broad-spectrum antibiotic effect.

View Article and Find Full Text PDF
Article Synopsis
  • Keloids are raised scars that can develop from various skin traumas, while pyoderma gangrenosum (PG) is a painful ulcerative skin condition linked to immune dysfunction; both have unclear causes.
  • A notable case involved a 24-year-old woman with a keloid on her chest that revealed a PG ulcer upon surgical removal, leading to complex post-surgery complications.
  • After treatment for PG, relapsed keloids appeared, suggesting that careful management is key for patients with PG and a history of keloid formation, with options like corticosteroid taping being considered the safest.
View Article and Find Full Text PDF

Accurate burn depth assessment is essential to decide an appropriate surgical procedure. However, most cases of burn depth are diagnosed with subjective judgment by an experienced plastic surgeon. There is a need for a simple, noninvasive, and accurate diagnostic method.

View Article and Find Full Text PDF

Bone marrow-derived mesenchymal stem cells (BM-MSC) has been applied as the most valuable source of autologous cell transplantation for various diseases including diabetic complications. However, hyperglycemia may cause abnormalities in intrinsic BM-MSC which might lose sufficient therapeutic effects in diabetic patients. We demonstrated the functional abnormalities in BM-MSC derived from both type 1 and type 2 diabetes models in vitro, which resulted in loss of therapeutic effects in vivo in diabetic nephropathy (DN).

View Article and Find Full Text PDF